SEC Form 4 · accession 0001209191-15-000207
Alaunos Therapeutics, Inc. · TCRT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Anthony Cannon
Director
Period of report
Dec 30, 2014
Accepted (ET)
Jan 2, 2015 · 4:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001107421
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 30, 2014 | F | 1,465 | $5.03 | D | 290,584 | D | |
| Common StockF1 | Dec 31, 2014 | F | 6,167 | $5.07 | D | 284,417 | D | |
| Common StockF2 | Dec 31, 2014 | A | 16,707 | $0.00 | A | 301,124 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares withheld to satisfy withholding tax obligations upon the vesting of a restricted stock grant.
- F216,707 shares vest on 12/31/2015.